NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/18/2024
Back to search
Official data from USPTO
BOTOX ONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BOTOX ONE
ST13
US500000087374234Class
35, 36
Filing
87374234
Registration
5734444
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
10/18/2024
Trademark type
Word
Nice classes
35, 36
Filing date
03/16/2017
Registration date
04/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2024
Last transaction
10/18/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/19/2019
First use in commerce
01/19/2019
Drawing code
4
Owner type
03
Owner location
North Chicago, IL, US
Examiner
LATTUCA, FRANK J
Current location
Historical data usage
Holders and representatives
Holders
Allergan, Inc.
Allergan, Inc.
Representatives
Matthew O. Brady
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing reimbursement support for licensed healthcare professionalsbusiness administration of patient reimbursement programs pertaining to therapeutic treatments in the field of neurologydermatologyurology
Class 36
Providing reimbursement support for licensed healthcare professionalsfinancial administration of patient reimbursement programs pertaining to therapeutic treatments in the field of neurologydermatologyurology
Publications
History of USPTO decisions and trademark events.
37 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/18/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/18/2024
E815
TEAS SECTION 8 & 15 RECEIVED
04/23/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/23/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/16/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/15/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/12/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/12/2019
IUAF
USE AMENDMENT FILED
02/20/2019
EISU
TEAS STATEMENT OF USE RECEIVED
02/20/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/26/2018
EX2G
SOU EXTENSION 2 GRANTED
07/24/2018
EXT2
SOU EXTENSION 2 FILED
07/24/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/24/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/22/2018
EX1G
SOU EXTENSION 1 GRANTED
02/20/2018
EXT1
SOU EXTENSION 1 FILED
02/20/2018
EEXT
SOU TEAS EXTENSION RECEIVED
02/20/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/29/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2017
PUBO
PUBLISHED FOR OPPOSITION
07/04/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/14/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/08/2017
ALIE
ASSIGNED TO LIE
05/05/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/05/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/05/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/05/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
04/28/2017
GPRA
PRIORITY ACTION E-MAILED
04/28/2017
CPRA
PRIORITY ACTION WRITTEN
04/28/2017
DOCK
ASSIGNED TO EXAMINER
04/24/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/22/2017
NWAP
NEW APPLICATION ENTERED
03/20/2017
Continuous trademark protection
Get notified about every new filing that threatens BOTOX ONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.